Botulinum Toxin

Botulinum Toxin

Global Botulinum Toxin Market to Reach $8.5 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Botulinum Toxin estimated at US$4.9 Billion in the year 2020, is projected to reach a revised size of US$8.5 Billion by 2027, growing at aCAGR of 8.2% over the period 2020-2027. Type A, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$8.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Type B segment is readjusted to a revised 6.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.9 Billion, While China is Forecast to Grow at 14.8% CAGR
The Botulinum Toxin market in the U.S. is estimated at US$2.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$762.1 Million by the year 2027 trailing a CAGR of 14.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 6.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Select Competitors (Total 28 Featured) -

  • AbbVie
  • Daewoong Pharmaceutical Co., Ltd.
  • HUGEL Pharma
  • Ipsen Group
  • Medy-Tox Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Metabiologics, Inc.
  • Revance Therapeutics, Inc.
  • US WorldMeds
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
COVID-19 Disruptions Impact Botulinum Toxin Business
Virtual Care to the Fore amid COVID-19
Aesthetic Clinics to Follow Infection-Prevention Measures to Mitigate Risk of COVID‐19 Infection Transmission
% Rise in Migraine Attacks due to COVID-19 Pandemic for March 2020
COVID-19 Disruptions Highlight Significance of Botulinum Toxin Therapy for Associated Medical Conditions
Researchers Eye on Botulinum Toxin as Potential Therapeutic Option to Alleviate and Manage COVID-19 Infection
Botulinum Toxin – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Botulinum Toxin: An Introduction
Outlook
Therapeutic BTX Applications Lead
Cosmetic BTX Gradually Gains Momentum
Factors Propelling the Cosmetic BT Market: In a Nut Shell
Percent of Plastic Surgeons Performing Botulinum Toxin Surgical Procedures in Select Countries: 2019
Developed Regions Dominate Botulinum Toxin Market
Developing Markets to Drive Future Growth
Competitive Landscape
Intense Competition Characterizes Botulinum Toxin Market
Market Share of Leading Players in Global Botulinum Toxin Market: 2019
Select Approved Botulinum Toxin Products Worldwide
Companies Entering the Fray
Pharma Companies Eye Lucrative BT Market
Biosimilar BTX Variants Challenge Botox’s Leadership
Lack of Differentiation among Approved BTX Products
Comparison of Leading Neurotoxins - Botox, Dysport and Xeomin by Safety and Efficacy
Comparison of Botox®, Dysport® and Xeomin® by Indications and Year of Approval
BOTOX®
Approvals and Indications of Botox in Select Regions
Botox Therapeutic Approvals in the US by Indication
Ipsen Counts on New Indications for Future Growth of Dysport
Xeomin®
Merz
Other Products
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Non-Invasive Cosmetic Treatments Bodes Well for BTX Market
Non-Surgical Cosmetic Procedures Worldwide (2018): Percentage Breakdown of Procedure Volumes
Botulinum Toxin: The Preferred Solution in Facial Injectables Market
Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Gender
Millennials: A Popular Demographic for Botulinum Toxin
Cosmetic Botulinum Toxin Procedures Performed Worldwide (2019): Percentage Breakdown of Procedure Volume by Age Group Age Group % Share
Therapeutic Areas and Opportunities
Botox Therapeutic Applications Uses and Indications
Global Therapeutic BTX Neurotoxin Market Breakdown by Therapeutic Indication (2019)
Botulinum Toxin Remains Gold Standard for Treatment of Focal Spasticity
Rise in the Number of Musculoskeletal Indications: Potential for Growth
Unmet Medical Needs Encourage Off-Label Use: A Cause for Concern or Jubilation?
Combination Therapies: A Double Whammy Success
Botulinum Toxin: Potential Applications in Treatment of Dental Diseases
Potential Applications in Dentistry
Short-lived Aesthetic Effects: A Strong Business Case for Revision Treatments
Novel Injection Systems for Highly Precise Dosage of Botulinum Toxin
Longer Life Expectancy and Rising Disposable Incomes Propel Sales of Cosmetic BTX
Life Expectancy at Birth in Years of People in Select Countries
Life Expectancy at Birth (in Years) of Men and Women by Region
Increase in Healthcare Spending Stirs Demand for BTX in Therapeutic Applications
Current Health Expenditure (CHE) as Percentage Of Gross Domestic Product (GDP) (%): 2017
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Challenges and Issues
Undesirable Side Effects: A Challenge to Reckon With
Immunogenicity Undermines Patient Compliance
Antigenicity: A Problematic Issue in Drug Development
Potential Adverse Side Effects: A Major Barrier to Success
Stringent Regulations Delay Market Approvals
Higher Product Costs to Challenge Market Growth
Consumer Skepticism: The Biggest Challenge to Beat
Animal Cruelty:A Part & Parcel of Botox Testing
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Type A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Type B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Aesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Specialty & Dermatology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
Market Overview
Opportunities in Store for Cosmetic BTX
Age-wise Distribution for Botulinum Toxin Procedures Performed in the US for the Year 2019
Gender Distribution for Botulinum Toxin Procedures Performed in the US (2019)
Increasing Demand for Cosmetic Treatments Bodes Well for BTX Market
Cosmetic Procedures: Facts and Figures
Number of Surgical & Non-Surgical Cosmetic Procedures ('000s) in the US for the Years 2000, 2018 & 2019
Top 5 Surgical Cosmetic Procedures in the US - Ranked by the Number of Procedures Performed (In ‘000s) for 2019
Top 4 Non-Surgical Cosmetic Procedures in the US - Ranked by the Number of Procedures Performed (‘000s) for 2019
Number of Botulinum Toxin Procedures* Performed in the US: 2000, 2016 and 2019
Aging Baby Boomers Drive Aesthetic Business
US Population by Age Group (2017): Percentage Breakdown for 0-14, 15-24, 25-59 and 65+ Age Groups
North American Aging Population by Age Group: 1975-2050
Expanding Physician Base Extends Impetus to Growth
Therapeutic BTX Seeks Growth Opportunities
Approved Therapeutic Indications of Botulinum Toxin in the US by Year of Approval
Neurogenic OAB: A Lucrative Market Opportunity
Competitive Landscape
Major BTX Products and Associated Fillers in the Cosmetic Botulinum Toxin Market
Market Share of Leading Brands in the US Boulinum Toxin Market: 2019
Dysport Poses Strong Competition to Botox in the Therapeutic Space
TABLE 25: USA Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 26: USA Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: USA 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 28: USA Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: USA Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: USA 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 31: USA Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: USA Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: USA 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
TABLE 34: Canada Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: Canada Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: Canada 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 37: Canada Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: Canada Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: Canada 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 40: Canada Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: Canada Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: Canada 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Market Overview
Non-Surgical Aesthetic Procedures in Japan (2019): Percentage Breakdown of Number of Procedures by Procedure Type Procedure % Share
TABLE 43: Japan Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: Japan Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: Japan 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 46: Japan Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: Japan Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: Japan 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 49: Japan Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Japan Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Japan 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Market Overview
Uptrend in Facial Injectables Market Favors Market Expansion
Regulatory Scenario
Approved Botulinum Toxin Injections in China
Competition
Market Share of Leading Players in Chinese Botulinum Toxin Market: 2019
TABLE 52: China Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: China Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: China 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 55: China Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: China Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: China 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 58: China Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: China Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: China 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Market Overview
Botox Approvals and Indications in Select European Countries
Non-Surgical Aesthetic Procedures in Select European Countries (2019): Percentage Breakdown of Number of Procedures by Procedure Type
Regulations for Botulinum Toxin Usage in the EU
TABLE 61: Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 62: Europe Historic Review for Botulinum Toxin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: Europe 15-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 64: Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Europe Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Europe 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 67: Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Europe Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Europe 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 70: Europe Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Europe Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Europe 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 73: France Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: France Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: France 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 76: France Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: France Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: France 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 79: France Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: France Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: France 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 82: Germany Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: Germany Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: Germany 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 85: Germany Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Germany Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Germany 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 88: Germany Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Germany Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Germany 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
TABLE 91: Italy Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Italy Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Italy 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 94: Italy Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Italy Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Italy 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 97: Italy Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Italy Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Italy 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
Market Overview
Snapshots
TABLE 100: UK Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 101: UK Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 102: UK 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 103: UK Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: UK Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 105: UK 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 106: UK Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: UK Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 108: UK 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
SPAIN
TABLE 109: Spain Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: Spain Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 111: Spain 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 112: Spain Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Spain Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 114: Spain 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 115: Spain Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: Spain Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 117: Spain 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
RUSSIA
Market Overview
TABLE 118: Russia Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: Russia Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 120: Russia 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 121: Russia Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: Russia Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 123: Russia 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 124: Russia Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: Russia Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 126: Russia 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 127: Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: Rest of Europe Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 129: Rest of Europe 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: Rest of Europe Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 132: Rest of Europe 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 133: Rest of Europe Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 134: Rest of Europe Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 135: Rest of Europe 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 137: Asia-Pacific Historic Review for Botulinum Toxin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 138: Asia-Pacific 15-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
TABLE 139: Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 140: Asia-Pacific Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 141: Asia-Pacific 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: Asia-Pacific Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 144: Asia-Pacific 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 145: Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: Asia-Pacific Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 147: Asia-Pacific 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
AUSTRALIA
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
Market Overview
Non-Surgical Aesthetic Procedures in Australia (2019): Percentage Breakdown of Number of Procedures by Procedure Type
TABLE 148: Australia Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 149: Australia Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 150: Australia 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 151: Australia Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Australia Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 153: Australia 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 154: Australia Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Australia Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 156: Australia 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
INDIA
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
Market Overview
Non-Surgical Aesthetic Procedures in India (2019): Percentage Breakdown of Number of Procedures by Procedure Type
TABLE 157: India Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: India Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 159: India 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 160: India Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: India Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 162: India 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 163: India Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: India Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 165: India 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
SOUTH KOREA
Market Overview
Strong Demand for Cosmetic Procedures – Potential for BTX Market
Working Women as % of Total Female Population for 2005, 2010, 2015 & 2018
Foreign Patients Visiting Korea for Plastic Surgery & Dermatology Procedures as a % of Total Visits of Foreign Patients
Competition
Market Share of Leading Players in Botulinum Toxin Market In South Korea
TABLE 166: South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 167: South Korea Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 168: South Korea 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 169: South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 170: South Korea Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 171: South Korea 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 172: South Korea Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 173: South Korea Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 174: South Korea 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 175: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 176: Rest of Asia-Pacific Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 177: Rest of Asia-Pacific 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 178: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 179: Rest of Asia-Pacific Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 180: Rest of Asia-Pacific 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 181: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 182: Rest of Asia-Pacific Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
LATIN AMERICA
Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 184: Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 185: Latin America Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 186: Latin America 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 187: Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 188: Latin America Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 189: Latin America 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 190: Latin America Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 191: Latin America Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 192: Latin America 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 193: Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by Product - Type A and Type B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 194: Rest of World Historic Review for Botulinum Toxin by Product - Type A and Type B Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 195: Rest of World 15-Year Perspective for Botulinum Toxin by Product - Percentage Breakdown of Value Sales for Type A and Type B for the Years 2012, 2021 & 2027
TABLE 196: Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by Application - Therapeutics and Aesthetics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 197: Rest of World Historic Review for Botulinum Toxin by Application - Therapeutics and Aesthetics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 198: Rest of World 15-Year Perspective for Botulinum Toxin by Application - Percentage Breakdown of Value Sales for Therapeutics and Aesthetics for the Years 2012, 2021 & 2027
TABLE 199: Rest of World Recent Past, Current & Future Analysis for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 200: Rest of World Historic Review for Botulinum Toxin by End-Use - Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 201: Rest of World 15-Year Perspective for Botulinum Toxin by End-Use - Percentage Breakdown of Value Sales for Specialty & Dermatology Clinics, Hospitals & Clinics and Other End-Uses for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 28

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings